Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Rash macular, SARS-CoV-2 test, Skin discolouration, Urticaria
Clinical narrative: developed various rashes, beginning on the torso and quickly moving to various body parts (arms, neck, back, face, ears, legs, hands and feet) accompanied by intense burning and itching.; developed various rashes, beginning on the torso and quickly moving to various body parts (arms, neck, back, face, ears, legs, hands and feet) accompanied by intense burning and itching.; developed various rashes, beginning on the torso and quickly moving to various body parts (arms, neck, back, face, ears, legs, hands and feet) accompanied by intense burning and itching.; Hive itchy patches and wheals that resemble hives.; Hive itchy patches and wheals that resemble hives.; Hive itchy patches and wheals that resemble hives.; Macules and papule itchy spots, both flat and raised.; Macules and papule itchy spots, both flat and raised.; Lace-like pattern with rings of skin discoloration that formed a lace or net-like pattern.; Pinpoint spots.; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 39 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 28Nov2021 13:00 (Lot number: FG3527) at the age of 39 years as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (prev dose product=COVID 19, prev dose brand=Pfizer, prev dose brand unknown=False, prev dose lot number=EL9264, prev dose lot unknown=False, prev dose administration date=22Feb2021, prev dose administration time=12:00, PM prev dose dose number=2, prev dose vaccine location=Left arm), administration date: 22Feb2021, when the patient was 38 years old, for Covid-19 Immunization; Bnt162b2 (prev dose product=COVID 19, prev dose brand=Pfizer, prev dose brand unknown=False, prev dose lot number=EN5318, prev dose lot unknown=False, prev dose administration date=29Jan2021, prev dose administration time=02:00PM , prev dose dose number=1, prev dose vaccine location=Left arm), administration date: 29Jan2021, when the patient was 38 years old, for COVID-19 immunization. The following information was reported: RASH (non-serious) with onset 28Jan2022 15:00, outcome "recovered" (01Feb2022 02:00), BURNING SENSATION (non-serious), PRURITUS (non-serious) all with onset 28Jan2022 14:00, outcome "recovered" (2022) and all described as "developed various rashes, beginning on the torso and quickly moving to various body parts (arms, neck, back, face, ears, legs, hands and feet) accompanied by intense burning and itching."; RASH (non-serious), URTICARIA (non-serious), URTICARIA (non-serious) all with onset 28Jan2022 14:00, outcome "recovered" (2022) and all described as "Hive itchy patches and wheals that resemble hives."; PAPULE (non-serious), MACULE (non-serious) all with onset 28Jan2022 14:00, outcome "recovered" (2022) and all described as "Macules and papule itchy spots, both flat and raised."; SKIN DISCOLOURATION (non-serious) with onset 28Jan2022 14:00, outcome "recovered" (2022), described as "Lace-like pattern with rings of skin discoloration that formed a lace or net-like pattern."; RASH MACULAR (non-serious) with onset 28Jan2022 14:00, outcome "recovered" (2022), described as "Pinpoint spots.". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of rash, burning sensation, pruritus, rash, urticaria, urticaria, papule, macule, skin discolouration, rash macular.  No follow-up attempts are possible. No further information is expected.